Visant Medical, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$136Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
10clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $65K
2020 $26K
2021 $10K
2022 $35K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Cardiovascular Disease $57K
Ophthalmology $48K
Ophthalmic Plastic and Reconstructive Surgery $30K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Steven Brooks Baltimore, MD Cardiovascular Disease $57,415.78
Mark Packer Boulder, CO Ophthalmology $47,209.33
John Fezza Venice, FL Ophthalmic Plastic and Reconstructive Surgery $30,000.00
Stephen Pflugfelder Houston, TX Ophthalmology $900.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.